[go: up one dir, main page]

AU5415390A - Vaccines for combatting septicemic bacteria - Google Patents

Vaccines for combatting septicemic bacteria

Info

Publication number
AU5415390A
AU5415390A AU54153/90A AU5415390A AU5415390A AU 5415390 A AU5415390 A AU 5415390A AU 54153/90 A AU54153/90 A AU 54153/90A AU 5415390 A AU5415390 A AU 5415390A AU 5415390 A AU5415390 A AU 5415390A
Authority
AU
Australia
Prior art keywords
bacteria
receptors
septicemic
combatting
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU54153/90A
Inventor
Jean-Christophe Audonnet
Patrick Bruneau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Animal Health France SAS
Original Assignee
Rhone Merieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9379871&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU5415390(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rhone Merieux SA filed Critical Rhone Merieux SA
Publication of AU5415390A publication Critical patent/AU5415390A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The bacteria expressing iron-regulated outer membrane proteins of which certain are siderophore or transferrin receptors can be used in a vaccinal preparation. Said bacteria are obtained from a culture in a medium in which the iron content is reduced to a level for obtaining an increased expression of said proteins, and in particular of receptors, sufficient to induce, when said bacteria are used in a vaccine, the formation of antibodies preventing the specific recognition of siderophores by their receptors.
AU54153/90A 1989-03-20 1990-03-19 Vaccines for combatting septicemic bacteria Abandoned AU5415390A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8903626A FR2644346B1 (en) 1989-03-20 1989-03-20 VACCINES AGAINST SEPTICEMIC BACTERIA, PREPARATIONS OF ANTIGENS OF SEPTICEMIC BACTERIA, NOVEL BACTERIA AND VECTORS FOR THE PREPARATION OF SUCH ANTIGENS OR VACCINES
FR8903626 1989-03-20

Publications (1)

Publication Number Publication Date
AU5415390A true AU5415390A (en) 1990-10-22

Family

ID=9379871

Family Applications (1)

Application Number Title Priority Date Filing Date
AU54153/90A Abandoned AU5415390A (en) 1989-03-20 1990-03-19 Vaccines for combatting septicemic bacteria

Country Status (8)

Country Link
EP (1) EP0389347B1 (en)
JP (1) JPH03143388A (en)
AT (1) ATE251666T1 (en)
AU (1) AU5415390A (en)
CA (1) CA2029906A1 (en)
DE (1) DE69034107T2 (en)
FR (1) FR2644346B1 (en)
WO (1) WO1990011349A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU649950B2 (en) * 1989-04-27 1994-06-09 University Technologies International Inc. A method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0563288B1 (en) * 1990-12-19 1999-03-03 Pfizer Inc. Immunopotentiation of vaccines, particularly swine pleuropneumonia vaccines
GB9112310D0 (en) * 1991-06-07 1991-07-24 United Kingdom Government Fish vaccine
FR2683147B1 (en) * 1991-10-30 1995-06-23 Maingault Philippe VEHICLE SYSTEM OF ACTIVE INGREDIENT FOR ORAL ADMINISTRATION IN FISH AND CRUSTACEANS.
US5554507A (en) * 1992-07-30 1996-09-10 American Cyanamid Company Bacillus subtilis siderophore genes
AU683221B2 (en) * 1992-09-04 1997-11-06 University Of Saskatchewan Novel bacterial vaccines using vaccine strains of pathogenic bacteria
US5830479A (en) * 1994-02-09 1998-11-03 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
WO1995021627A1 (en) * 1994-02-09 1995-08-17 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
US6682754B2 (en) 1999-11-24 2004-01-27 Willmar Poultry Company, Inc. Ovo delivery of an immunogen containing implant
CA2433561C (en) 2001-01-03 2014-04-01 Willmar Poultry Company, Inc. Compositions including gram negative siderophore receptor proteins and methods of use
US8329192B2 (en) 2003-09-19 2012-12-11 Epitopix Llc Campylobacter polypeptides and methods of use
US8729013B2 (en) 2004-08-26 2014-05-20 The University Of Western Ontario Methods of inhibiting staphylobactin-mediated iron uptake in S. aureus
WO2010123845A2 (en) 2009-04-21 2010-10-28 University Of Florida Research Foundation, Inc. Siderophore conjugate immunogenic compositions and vaccines
WO2011131789A1 (en) 2010-04-23 2011-10-27 Intervet International B.V. A vaccine comprising inactivated cells of haemophilus parasuis bacteria of serotype 5
JP7222711B2 (en) * 2015-07-10 2023-02-15 エピトピックス， エルエルシー Immunization compositions containing proteins and KLEBSIELLA proteins and methods of use thereof
US10166280B2 (en) 2016-06-08 2019-01-01 Epitopix, Llc Polypeptides and immunizing compositions containing Bacillus polypeptides and methods of use

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU649950B2 (en) * 1989-04-27 1994-06-09 University Technologies International Inc. A method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same

Also Published As

Publication number Publication date
WO1990011349A1 (en) 1990-10-04
FR2644346A1 (en) 1990-09-21
FR2644346B1 (en) 1994-05-13
JPH03143388A (en) 1991-06-18
EP0389347A1 (en) 1990-09-26
ATE251666T1 (en) 2003-10-15
EP0389347B1 (en) 2003-10-08
CA2029906A1 (en) 1990-09-21
DE69034107T2 (en) 2004-07-22
DE69034107D1 (en) 2003-11-13

Similar Documents

Publication Publication Date Title
AU5415390A (en) Vaccines for combatting septicemic bacteria
HU9203098D0 (en) Living vaccine
AU4533589A (en) Skin test and test kit for aids
DE69333802T8 (en) OUTER MEMBRANE PROTEIN FROM HAEMOPHILUS
DK325486A (en) PROCEDURE FOR THE PROMOTION OF BACTERIA'S ADMINISTRATION TO MAVE GAS ANIMALS AND HUMANS AND PREPARATIONS FOR USING THE PROCEDURE
DE3175677D1 (en) Polysaccharide antigen from streptococcus and vaccines
ATE78403T1 (en) VACCINE AGAINST MASTITIS.
GB1508878A (en) Hepatitis a antigen
ATE105938T1 (en) MONOCLONAL ANTIBODIES AGAINST SPECIFIC ANTIGENIC REGIONS OF HUMAN IMMUNODEFICIENCY VIRUS AND METHODS FOR USE.
AU1681095A (en) Hydrophilic signal oligopeptides and methods of therapeutic use
FR2577048B1 (en) REAGENT FOR THE HEMAGGLUTINATION DETERMINATION OF ANTIBODIES AGAINST BACTERIAL TOXINS, METHOD OF PREPARATION AND ITS APPLICATION
GR3006970T3 (en)
DE3272729D1 (en) Hepatitis-a viruses adapted to human fibroblast cells
SE8201128L (en) PROCEDURE FOR REPRODUCTION OF VIRULENT TREPONEMA PALLIDUM IN TISSUE ULTUR
DE3781421D1 (en) METHOD FOR DETECTING INFECTION OR INFLAMMATION OF THE URINAL TRACTUS.
DE59708140D1 (en) USE OF AN IMMUNOGLOBULIN PREPARATION FOR THE PRODUCTION OF AN ORAL MEDICINE TO PREVENT THE HEMOLYTIC UREMAL SYNDROME AND PREPARATION THEREFOR
AU532186B2 (en) Herpes virus vaccine
GB2248186A (en) Preparation of vaccines
PT83368A (en) Process for propagating microorganisms in vivo by using cell lines which lack human class ii histocompatibility antigens
AU7377296A (en) Method for treating hepatitis virus infection
EP0309898A3 (en) Method for the induction of a cytotoxic t cell response
UA39348A (en) Method for obtaining extracellular diphtheria antigen
WO1991008771A3 (en) Method for intensive, in vitro culture of babesia divergens strains, method for preparing exoantigens and vaccines containing these antigens
Zourbas et al. Immunization of dental surgeons against hepatitis B virus infection.
GB1206718A (en) Vaccine for use against brucelloses